Drug intelligence / Profile preview

Duro Tuss

Development stage: Unknown
Lead developer: iNova Pharmaceuticals
Administration: Oral

Overview

**DURO-TUSS** is an iNova Pharmaceuticals over-the-counter cough-and-cold medicine brand rather than a single drug substance. Its regional product range includes oral liquids, tablets, capsules, and lozenges for dry cough, chesty cough, cough associated with colds, and paediatric cough symptoms. Individual DURO-TUSS products have distinct active ingredients and mechanisms: examples include dextromethorphan as an antitussive, bromhexine as a mucolytic, guaifenesin as an expectorant, herbal marshmallow preparations for throat soothing, and country-specific formulations containing other ingredients. Consequently, the unqualified name does not identify one uniform composition, mechanism, dosage form, or route of administration. ([durotuss.com.au](https://durotuss.com.au/faq/))

Brand names: DURO-TUSS
Other names: Duro Tuss

Beyond the preview

Go deeper on Duro Tuss.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duro Tuss.

Explore the full profile